01.22.26 -- Trump's Big Pharma Deals Drive CDMO Investments

Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.

Efficient CDMO audits hinge on smart planning, clear communication, and real-time documentation to reduce risk, boost compliance, and protect profitability.

The revised EU GMP Annex 1 prioritizes a CCS. Learn how to holistically manage microbial, particulate, chemical, and cross-contamination risks to ensure product sterility and patient safety.

A practical guide for adding oversight, based on a hierarchy of metrics, to quality agreements to transform them into living, metrics-driven control instruments.

Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

Biopharma success starts with the right CDMO, one that brings full-service capabilities, scientific know-how, a culture of quality, flexibility, and open collaboration from idea to market.

Take proactive steps now to reduce development costs, accelerate approval, and unlock new opportunities in the shifting biosimilar landscape.

Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.

Optimize your validation strategy to meet evolving regulatory demands and product complexities with a scalable, efficient framework that accelerates facility readiness and ensures consistent quality.

Here, we review several challenges in biologics analysis and take a closer look at the advanced tools and methods being utilized to improve biophysical analysis reliability and efficiency.

Whether you’re at the discovery stage or thinking about commercial production, gain useful insights on expression formats from transient transfection, through stable pools to stable clones.

Move drug development into the modern era with a CRO that offers assay development and validation, bioanalytical testing, sample prep, and more.

Comprehensive lab services support all drug phases with analytical development, raw material testing, and microbiology expertise.

Leverage platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support discovery.

Sterile fill/finish requires isolator technology and regulatory compliance. From clinical development to commercial scale, technical expertise ensures the integrity of liquid and lyophilized injectables.